Global GLP-1 Agonist Market Growth 2023-2029

Global GLP-1 Agonist Market Growth 2023-2029

The global GLP-1 Agonist market size is projected to grow from US$ 20150 million in 2022 to US$ 61280 million in 2029; it is expected to grow at a CAGR of 17.2% from 2023 to 2029.

United States market for GLP-1 Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for GLP-1 Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for GLP-1 Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key GLP-1 Agonist players cover Novo Nordisk, AstraZeneca, Sanofi, GSK, Eli Lilly, Zealand Pharma A/S, hansoh and BENEMAE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.

LPI (LP Information)' newest research report, the “GLP-1 Agonist Industry Forecast” looks at past sales and reviews total world GLP-1 Agonist sales in 2022, providing a comprehensive analysis by region and market sector of projected GLP-1 Agonist sales for 2023 through 2029. With GLP-1 Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Agonist industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global GLP-1 Agonist market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Agonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Agonist.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Agonist market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Long-Acting Drug
Short-Acting Drug

Segmentation by application
Diabetes
Obesity
Nonalcoholic Fatty Liver Disease
Metabolic Disorder
Alzheimer's Disease
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
AstraZeneca
Sanofi
GSK
Eli Lilly
Zealand Pharma A/S
hansoh
BENEMAE

Key Questions Addressed in this Report

What is the 10-year outlook for the global GLP-1 Agonist market?

What factors are driving GLP-1 Agonist market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GLP-1 Agonist market opportunities vary by end market size?

How does GLP-1 Agonist break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.